These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2735259)

  • 1. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
    Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K
    Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis.
    Dorfman M; Barsanti J; Budsberg SC
    Am J Vet Res; 1995 Mar; 56(3):386-90. PubMed ID: 7771709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostatic tissue and fluid levels of DL-8280].
    Kumon H; Furukawa M; Mizuno A; Miyata K; Akazawa N; Ohmori H; Katayama Y; Akaeda T
    Hinyokika Kiyo; 1984 Sep; 30(9):1297-305. PubMed ID: 6596879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lomefloxacin in the treatment of chronic prostatitis.
    Scelzi S; Travaglini F; Nerozzi S; Dominici A; Ponchietti R; Novelli A; Rizzo M
    J Chemother; 2001 Feb; 13(1):82-7. PubMed ID: 11233805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy--rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue.
    Naber KG; Sörgel F
    Andrologia; 2003 Oct; 35(5):331-5. PubMed ID: 14535866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concentrations of new quinolone agents in serum and prostate tissue].
    Imai K; Suzuki K; Yamanaka H; Makino T; Yazima H; Takezawa Y; Kitaura K; Shiono A; Sato J; Kato N
    Hinyokika Kiyo; 1994 May; 40(5):401-6. PubMed ID: 7517621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion of tosufloxacin into prostatic tissue.
    Uchibayashi T; Hisazumi H; Kanayama J; Kumano K
    Chemotherapy; 1992; 38(3):150-4. PubMed ID: 1380905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient].
    Tanaka K; Nakano Y; Ono Y; Hirabayashi S; Yamada S
    Hinyokika Kiyo; 1988 Nov; 34(11):2067-9. PubMed ID: 3242374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of rufloxacin into human prostatic tissue and fluid.
    Boerema JB; Bach D; Jol C; Pahlmann W
    J Antimicrob Chemother; 1991 Oct; 28(4):547-54. PubMed ID: 1662190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diffusion of cefmenoxime into prostatic fluid in the patients with acute bacterial prostatitis].
    Katoh N; Sugiyama T; Ono Y; Hirabayashi S
    Hinyokika Kiyo; 1990 Nov; 36(11):1287-93. PubMed ID: 2288308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial substances in prostatic fluid.
    Fair WR; Parrish RF
    Prog Clin Biol Res; 1981; 75A():247-64. PubMed ID: 7041133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Grise P; Dhib M; Valtchev B; Fillastre JP
    Urology; 1991 Aug; 38(2):192. PubMed ID: 1877143
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections].
    Iakovlev SV
    Urologiia; 2002; (1):11-4. PubMed ID: 11877963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin.
    Bahk JY; Hyun JS; Lee JY; Kim J; Cho YH; Lee JH; Park JS; Kim MO
    J Urol; 2000 May; 163(5):1560-4. PubMed ID: 10751888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
    Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose].
    Guibert J; Kitzis MD; Acar JF; Masquelier AM; Bellanger B
    Pathol Biol (Paris); 1989 May; 37(5):411-4. PubMed ID: 2506515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraprostatic distribution of lomefloxacin following multiple-dose administration.
    Kovarik JM; de Hond JA; Hoepelman IM; Boon T; Verhoef J
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2398-401. PubMed ID: 2088193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Zinc levels in prostatic fluid of patients with prostate pathologies].
    Gómez Y; Arocha F; Espinoza F; Fernández D; Vásquez A; Granadillo V
    Invest Clin; 2007 Sep; 48(3):287-94. PubMed ID: 17853788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.